Specify a stock or a cryptocurrency in the search bar to get a summary
Biosergen AS
BIOSGNBiosergen AB, a biotech company, develops antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of fungal infections. The company was founded in 2004 and is based in Solna, Sweden. Address: Fogdevreten 2, Solna, Sweden, 171 65
Analytics
WallStreet Target Price
10.75 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BIOSGN
Dividend Analytics BIOSGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIOSGN
Stock Valuation BIOSGN
Financials BIOSGN
Results | 2019 | Dynamics |